AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,645,000 | +21.5% | 494,234 | -1.1% | 0.00% | 0.0% |
| Q2 2020 | $3,824,000 | +23.7% | 499,916 | -0.1% | 0.00% | 0.0% |
| Q1 2020 | $3,092,000 | -73.2% | 500,487 | -47.3% | 0.00% | 0.0% |
| Q4 2019 | $11,552,000 | +118.4% | 949,252 | +107.3% | 0.00% | 0.0% |
| Q3 2019 | $5,290,000 | +16.0% | 458,019 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $4,561,000 | -25.5% | 456,666 | -3.9% | 0.00% | -50.0% |
| Q1 2019 | $6,119,000 | -53.7% | 475,087 | -45.4% | 0.00% | 0.0% |
| Q4 2018 | $13,208,000 | +51.7% | 869,610 | +99.7% | 0.00% | 0.0% |
| Q3 2018 | $8,708,000 | +10.4% | 435,488 | +7.7% | 0.00% | 0.0% |
| Q2 2018 | $7,885,000 | +5.9% | 404,450 | +9.4% | 0.00% | 0.0% |
| Q1 2018 | $7,446,000 | +48.9% | 369,556 | -2.1% | 0.00% | 0.0% |
| Q4 2017 | $5,001,000 | -27.1% | 377,479 | +1.5% | 0.00% | -33.3% |
| Q3 2017 | $6,863,000 | +2.7% | 372,027 | +2.4% | 0.00% | 0.0% |
| Q2 2017 | $6,684,000 | -18.2% | 363,318 | +0.2% | 0.00% | 0.0% |
| Q1 2017 | $8,173,000 | -23.2% | 362,488 | +18.5% | 0.00% | -40.0% |
| Q4 2016 | $10,648,000 | +49.3% | 305,995 | +5.2% | 0.01% | +25.0% |
| Q3 2016 | $7,131,000 | +5.1% | 290,985 | +2.6% | 0.00% | 0.0% |
| Q2 2016 | $6,784,000 | +10.3% | 283,649 | +7.9% | 0.00% | +33.3% |
| Q1 2016 | $6,150,000 | -19.4% | 262,848 | +4.0% | 0.00% | -25.0% |
| Q4 2015 | $7,631,000 | -18.2% | 252,781 | +7.6% | 0.00% | -33.3% |
| Q3 2015 | $9,333,000 | -31.8% | 234,931 | +18.5% | 0.01% | -25.0% |
| Q2 2015 | $13,688,000 | +44.8% | 198,209 | +14.6% | 0.01% | +60.0% |
| Q1 2015 | $9,453,000 | +70.8% | 172,968 | +33.2% | 0.01% | +66.7% |
| Q4 2014 | $5,533,000 | +36.9% | 129,855 | +2.5% | 0.00% | 0.0% |
| Q3 2014 | $4,043,000 | +56.8% | 126,722 | +1.8% | 0.00% | +50.0% |
| Q2 2014 | $2,579,000 | +10.8% | 124,509 | +3.5% | 0.00% | 0.0% |
| Q1 2014 | $2,328,000 | -18.1% | 120,344 | +2.8% | 0.00% | 0.0% |
| Q4 2013 | $2,842,000 | +21.0% | 117,114 | +7.2% | 0.00% | 0.0% |
| Q3 2013 | $2,348,000 | -0.8% | 109,289 | +2.8% | 0.00% | 0.0% |
| Q2 2013 | $2,366,000 | – | 106,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Voce Capital Management LLC | 94,109 | $1,732,000 | 3.74% |
| Palo Alto Investors LP | 3,344,620 | $61,541,000 | 2.87% |
| Breithorn Capital Management | 143,700 | $2,644,000 | 1.87% |
| FALCON POINT CAPITAL, LLC | 672,302 | $12,370,000 | 1.67% |
| Camber Capital Management LP | 1,700,000 | $31,280,000 | 1.52% |
| UNIVERSITY OF NOTRE DAME DU LAC | 123,140 | $2,266,000 | 0.67% |
| EII CAPITAL MANAGEMENT, INC. | 84,600 | $1,557,000 | 0.52% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,354 | $706,000 | 0.51% |
| CLARK ESTATES INC/NY | 150,100 | $2,762,000 | 0.48% |
| Credit Capital Investments LLC | 15,000 | $276,000 | 0.37% |